Video yükleniyor...

Video Yüklenemedi

Bu video yüklenirken bir sorun oluştu. Bu geçici bir ağ sorunundan kaynaklanıyor olabilir veya video kullanılamıyor olabilir.

Ana Sayfaya Dön

When should early treatment intensification w/ PARPi + ARPI combination be considered for mCRPC patients? 📺 Find out in this patient case video >> You’ll also discover the SHARE Communication Framework to use with your pts in clinical practice SHARE is made up of 5 key elements: S –... show more

GU CONNECT powered by COR2ED

1,280 subscribers

164,512 görüntüleme • 7 ay önce •via X (Twitter)

Anya Rossi• Live Now

Private livecam show

0 Yorum

Yorum bulunmuyor

Orijinal gönderinin yorumları burada görünecek

Benzer Videolar

Personalised treatment in childhood cancer: A journey through 𝘕𝘛𝘙𝘒 fusion testing 📺Video for patients & families – please share with your network From Linet Menachery, patient advocate and mother of a child diagnosed with an 𝘕𝘛𝘙𝘒 fusion-positive pediatric cancer Endorsed by NTRKers, ICAN, International Cancer Advocacy Network & Biomarker Collaborative Supported by an Independent Educational Grant from Bayer

Personalised treatment in childhood cancer: A journey through 𝘕𝘛𝘙𝘒 fusion testing 📺Video for patients & families – please share with your network From Linet Menachery, patient advocate and mother of a child diagnosed with an 𝘕𝘛𝘙𝘒 fusion-positive pediatric cancer Endorsed by NTRKers, ICAN, International Cancer Advocacy Network & Biomarker Collaborative Supported by an Independent Educational Grant from Bayer

COR2ED

5,214,734 görüntüleme • 5 ay önce

Navigating extrapulmonary neuroendocrine carcinoma (EP-NEC) >> This is a rare and complex cancer that needs early diagnosis and intervention 📺 Watch the video from Meredith Cummins, INCA President-Elect, and CEO of NeuroEndocrine Cancer Australia, to find out: -Why urgency is needed in diagnosis & treatment -The potential of investigational treatments -Where to find support Endorsed by: INCA (NET Cancer Day). NeuroEndocrine Cancer Australia, Neuroendocrine Cancer UK #NotJustNECancer, Neuroendocrine Cancer Foundation, Neuroendocrine Cancer Research Foundation & Minkahz NETs Mission Supported by an Independent Educational Grant from Boehringer Ingelheim

Navigating extrapulmonary neuroendocrine carcinoma (EP-NEC) >> This is a rare and complex cancer that needs early diagnosis and intervention 📺 Watch the video from Meredith Cummins, INCA President-Elect, and CEO of NeuroEndocrine Cancer Australia, to find out: -Why urgency is needed in diagnosis & treatment -The potential of investigational treatments -Where to find support Endorsed by: INCA (NET Cancer Day). NeuroEndocrine Cancer Australia, Neuroendocrine Cancer UK #NotJustNECancer, Neuroendocrine Cancer Foundation, Neuroendocrine Cancer Research Foundation & Minkahz NETs Mission Supported by an Independent Educational Grant from Boehringer Ingelheim

COR2ED

757,945 görüntüleme • 7 ay önce

Are ADCs the next therapeutic options for pts w/ pretreated HR+/HER2- (IHC 0) metastatic breast cancer who have developed an endocrine resistance? Find out as you follow a pt journey in this case-based video Endorsed by ICAN, International Cancer Advocacy Network Biomarker Collaborative GRASP & Exon 20 Group, a multistakeholder organization Supported by an Independent Educational Grant from AstraZeneca.

Are ADCs the next therapeutic options for pts w/ pretreated HR+/HER2- (IHC 0) metastatic breast cancer who have developed an endocrine resistance? Find out as you follow a pt journey in this case-based video Endorsed by ICAN, International Cancer Advocacy Network Biomarker Collaborative GRASP & Exon 20 Group, a multistakeholder organization Supported by an Independent Educational Grant from AstraZeneca.

BREAST CANCER CONNECT

1,019,784 görüntüleme • 11 ay önce

GI CONNECT podcast episode Tackling metastatic pancreatic ductal adenocarcinoma (mPDAC) Dr. Shubham Pant & Prof. Efrat Dotan MD discuss chemotherapy strategies that matter Conversation topics include: - Efficacy & safety profiles - Relevance of mode of delivery - Cause of toxicities - Strategies to manage side effects 📹 Highlights video in this post Endorsed by ICAN, International Cancer Advocacy Network Digestive Cancers Europe The National Pancreas Foundation PanCAN Supported by an Independent Educational Grant from Ipsen USA

GI CONNECT podcast episode Tackling metastatic pancreatic ductal adenocarcinoma (mPDAC) Dr. Shubham Pant & Prof. Efrat Dotan MD discuss chemotherapy strategies that matter Conversation topics include: - Efficacy & safety profiles - Relevance of mode of delivery - Cause of toxicities - Strategies to manage side effects 📹 Highlights video in this post Endorsed by ICAN, International Cancer Advocacy Network Digestive Cancers Europe The National Pancreas Foundation PanCAN Supported by an Independent Educational Grant from Ipsen USA

GI CONNECT powered by COR2ED

1,202,878 görüntüleme • 10 ay önce

🧬 What do HCPs need to know about current treatment options for advanced/recurrent EndometrialCancer? An animated MedEd video from Prof. Christian Marth 📺 Hear about 👉 A patient case study 👉 Latest treatment strategies 👉 A shift from traditional chemotherapy to personalised therapies driven by molecular profiling. This educational programme is sponsored by an Independent Educational Grant from Eisai Europe Limited ("Eisai"). Eisai has had no input on the educational content of or speakers involved in this programme.

🧬 What do HCPs need to know about current treatment options for advanced/recurrent EndometrialCancer? An animated MedEd video from Prof. Christian Marth 📺 Hear about 👉 A patient case study 👉 Latest treatment strategies 👉 A shift from traditional chemotherapy to personalised therapies driven by molecular profiling. This educational programme is sponsored by an Independent Educational Grant from Eisai Europe Limited ("Eisai"). Eisai has had no input on the educational content of or speakers involved in this programme.

OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED

240,514 görüntüleme • 1 yıl önce

🧬 What do HCPs need to know about current treatment options for advanced/recurrent #EndometrialCancer? An animated #MedEd video from Prof. Christian Marth 📺 Hear about 👉 A patient case study 👉 Latest treatment strategies 👉 A shift from traditional chemotherapy to personalised therapies driven by molecular profiling. This educational programme is sponsored by an Independent Educational Grant from Eisai Europe Limited ("Eisai"). Eisai has had no input on the educational content of or speakers involved in this programme. #Oncology #GynecologicCancer

🧬 What do HCPs need to know about current treatment options for advanced/recurrent #EndometrialCancer? An animated #MedEd video from Prof. Christian Marth 📺 Hear about 👉 A patient case study 👉 Latest treatment strategies 👉 A shift from traditional chemotherapy to personalised therapies driven by molecular profiling. This educational programme is sponsored by an Independent Educational Grant from Eisai Europe Limited ("Eisai"). Eisai has had no input on the educational content of or speakers involved in this programme. #Oncology #GynecologicCancer

OBSTETRICS & GYNECOLOGY CONNECT

462,512 görüntüleme • 1 yıl önce

A personal message: Five years ago, my younger brother was diagnosed with an aggressive form of brain cancer. While we’re incredibly grateful that he responded well to treatment, the sad reality is that too many families of pediatric cancer patients aren’t as lucky. Please take a moment to watch his video, and if you can, send a message to your state’s U.S. Senators to urge them to vote yes on the Mikaela Naylon Give Kids a Chance Act. This bipartisan legislation aims to expedite the process of developing new treatment options for pediatric patients by providing the FDA with the authority to compel pharmaceutical companies to study the efficacy of combination drug therapies in children. This will help increase survival rates while minimizing treatment-induced side effects, many of which are irreversible. In return, the companies can receive priority review vouchers, which is mutually beneficial to the pediatric patients as it makes new drugs available sooner. In addition to reaching out to your Senators, please share this with as many people as you can, and thank you for supporting kids like my brother. Kids V Cancer

A personal message: Five years ago, my younger brother was diagnosed with an aggressive form of brain cancer. While we’re incredibly grateful that he responded well to treatment, the sad reality is that too many families of pediatric cancer patients aren’t as lucky. Please take a moment to watch his video, and if you can, send a message to your state’s U.S. Senators to urge them to vote yes on the Mikaela Naylon Give Kids a Chance Act. This bipartisan legislation aims to expedite the process of developing new treatment options for pediatric patients by providing the FDA with the authority to compel pharmaceutical companies to study the efficacy of combination drug therapies in children. This will help increase survival rates while minimizing treatment-induced side effects, many of which are irreversible. In return, the companies can receive priority review vouchers, which is mutually beneficial to the pediatric patients as it makes new drugs available sooner. In addition to reaching out to your Senators, please share this with as many people as you can, and thank you for supporting kids like my brother. Kids V Cancer

Ryan Shenker

24,493 görüntüleme • 8 ay önce

$What if Biden's accelerated physical and cognitive decline was in part a result of hormonal treatment for prostate cancer? DR. JAMIN BRAHMBATT, ON CNN: "One of the biggest side effects that I see in my patients that get these hormone treatments could be cognitive changes. So you have to kind of balance that people can also get issues with fatigue and weight loss. But when he has stuff in his bones, he's also at higher risk for fractures. So it is it is a very sensitive conversation."$

What if Biden's accelerated physical and cognitive decline was in part a result of hormonal treatment for prostate cancer? DR. JAMIN BRAHMBATT, ON CNN: "One of the biggest side effects that I see in my patients that get these hormone treatments could be cognitive changes. So you have to kind of balance that people can also get issues with fatigue and weight loss. But when he has stuff in his bones, he's also at higher risk for fractures. So it is it is a very sensitive conversation."

Jorge Bonilla

460,164 görüntüleme • 1 yıl önce

🚨🚨 10 simple questions every cancer patient should ask their doctor before starting any treatment, especially chemotherapy: 1. Does this treatment really cure my cancer? 2. What caused my cancer in the first place? 3. If it doesn't cure it, what can I expect in the long term? 4. What side effects should I expect? 5. Can the treatment itself create more diseases? 6. How will those side effects be managed? 7. What will happen to my quality of life during the treatment? 8. How much are you earning from this treatment? 9. How much is the hospital earning? 10. Can I speak with patients who have already gone through this? Most people never ask these questions... They just follow the instructions... Dr. Peter Glidden. Follow me.

🚨🚨 10 simple questions every cancer patient should ask their doctor before starting any treatment, especially chemotherapy: 1. Does this treatment really cure my cancer? 2. What caused my cancer in the first place? 3. If it doesn't cure it, what can I expect in the long term? 4. What side effects should I expect? 5. Can the treatment itself create more diseases? 6. How will those side effects be managed? 7. What will happen to my quality of life during the treatment? 8. How much are you earning from this treatment? 9. How much is the hospital earning? 10. Can I speak with patients who have already gone through this? Most people never ask these questions... They just follow the instructions... Dr. Peter Glidden. Follow me.

Joe Tippens

30,959 görüntüleme • 4 ay önce

Survey results published: Patient understanding of biomarker testing in non-small cell lung cancer (NSCLC) We surveyed patients & caregivers to assess awareness, knowledge & attitudes surrounding biomarker testing in NSCLC 📹 The results highlight gaps we can address to better support shared decision-making From medical experts Prof. Christian Rolfo , Prof. Fernando López-Ríos & Dr Rodrigo Paredes, MD , and made in collaboration with patient advocacy experts Dr. Amy C. Moore, Dr Anne-Marie Baird & Shani Shilo This programme is endorsed by LUNGevity Foundation, The Israeli Lung Cancer Foundation, NTRKers & Biomarker Collaborative Supported by an Independent Educational Grant from Bayer

Survey results published: Patient understanding of biomarker testing in non-small cell lung cancer (NSCLC) We surveyed patients & caregivers to assess awareness, knowledge & attitudes surrounding biomarker testing in NSCLC 📹 The results highlight gaps we can address to better support shared decision-making From medical experts Prof. Christian Rolfo , Prof. Fernando López-Ríos & Dr Rodrigo Paredes, MD , and made in collaboration with patient advocacy experts Dr. Amy C. Moore, Dr Anne-Marie Baird & Shani Shilo This programme is endorsed by LUNGevity Foundation, The Israeli Lung Cancer Foundation, NTRKers & Biomarker Collaborative Supported by an Independent Educational Grant from Bayer

LUNG CONNECT powered by COR2ED

2,703,909 görüntüleme • 1 ay önce

CANCER IS REAL BUSINESS Dr. Stanislaw Burzynski's unconventional cancer treatment has sparked intense debate. His Antineoplaston therapy has inspired hope in some, but the medical mainstream remains skeptical. Devotees see him as a visionary, while detractors dismiss him as a quack. The controversy raises important questions about the future of cancer treatment. Can conventional and alternative approaches find common ground? How can we balance innovation with rigor and oversight? The answers will have far-reaching implications for patients and the medical community. The debate around Dr. Stanislaw Burzynski's cancer treatment is complicated by the FDA's involvement. Critics argue that the agency's oversight has hindered Burzynski's efforts, citing instances of bureaucratic delays and stringent regulations that can slow down the approval process for new treatments. Some claim the FDA's stance is influenced by a preference for conventional therapies and pressure from the pharmaceutical industry, suggesting the agency's actions are more about protecting established interests than safeguarding patients. However, others believe the FDA is fulfilling its role of ensuring treatments meet high safety and efficacy standards. They assert that Burzynski's methods have yet to be convincingly validated and express concerns about potential risks associated with his treatment. The reality may be somewhere in the middle. While the FDA aims to protect patients, its approach can sometimes be perceived as overly strict. Finding a balance between promoting innovation and maintaining robust oversight is key to offering patients safe, effective cancer treatments while also fostering progress in medical research.

CANCER IS REAL BUSINESS Dr. Stanislaw Burzynski's unconventional cancer treatment has sparked intense debate. His Antineoplaston therapy has inspired hope in some, but the medical mainstream remains skeptical. Devotees see him as a visionary, while detractors dismiss him as a quack. The controversy raises important questions about the future of cancer treatment. Can conventional and alternative approaches find common ground? How can we balance innovation with rigor and oversight? The answers will have far-reaching implications for patients and the medical community. The debate around Dr. Stanislaw Burzynski's cancer treatment is complicated by the FDA's involvement. Critics argue that the agency's oversight has hindered Burzynski's efforts, citing instances of bureaucratic delays and stringent regulations that can slow down the approval process for new treatments. Some claim the FDA's stance is influenced by a preference for conventional therapies and pressure from the pharmaceutical industry, suggesting the agency's actions are more about protecting established interests than safeguarding patients. However, others believe the FDA is fulfilling its role of ensuring treatments meet high safety and efficacy standards. They assert that Burzynski's methods have yet to be convincingly validated and express concerns about potential risks associated with his treatment. The reality may be somewhere in the middle. While the FDA aims to protect patients, its approach can sometimes be perceived as overly strict. Finding a balance between promoting innovation and maintaining robust oversight is key to offering patients safe, effective cancer treatments while also fostering progress in medical research.

Teaᡣ𐭩

125,284 görüntüleme • 2 yıl önce

Another defamation case in the works? Ok. Will not apologize. Will not delete. But will apologise and delete if: 1) Institution of national repute will put out a public statement that they will ensure all patients - from all wakes of life will be treated with evidence-based scientific medicine without prejudice and not Ayurvedic quackery. If the patient wants Ayurvedic quackery then the doctors must counsel them on cons of the treatment because there are no pros. The final decision can be with the patient after a wholesome discussion. 2) Call back this patient with bipolar (see last video l) who received toxic ayurvedic products as part of bipolar mania treatment and provide actual guidelines based medical care. 3) Ayurveda practitioners who prescribed the set of herbals to the bipolar patient must show evidence for their treatment from classical as well as modern medical literature, mechanism of action, dosing studies, safety profile of each herbal and multi herbal combinations in this group of patients. The amount of abuses and harassment that alumni of NIMHANS showered on my Instagram was quite a lot. They were all worried about the "name" of their institute getting tarnished...NOT A SINGLE DOCTOR from NIMHANS reached out or responded asking how the patient was or about the atrocity committed against the patient. Not one. Patients do not go to NIMHANS for Ayurvedic treatment. If real doctors don't stand up for their patients, then who will? I know doctors who work in NIMHANS and such government run institutes are held hostage and scared. But I am not, because I am only concerned about patients and their family. And their right to healthcare. I vehemently stand against integrative quackery. And every doctor should too, if they have an iota of conscience and humanism left for their patients, past-present-and future.

TheLiverDoc™

42,797 görüntüleme • 1 yıl önce

Megyn Kelly sat down with Dr. Patrick Soon-Shiong to discuss his revolutionary cancer protocol—a treatment that has already extended lives by years for patients with terminal diagnoses, including the late Senator Harry Reid. The Science Behind the Breakthrough Dr. Soon-Shiong’s approach challenges conventional cancer treatments like chemotherapy and radiation, which destroy the immune system’s natural killer (NK) cells and T-cells—critical for fighting cancer. His BioStripe treatment works by rebuilding the immune system, even in patients who have exhausted all other options. Real Patients, Miraculous Results Merkel cell carcinoma (5th-line treatment): Complete remission—patient lived 6+ years and didn’t die from cancer. Bladder cancer: Patients still alive 10-11 years later. Triple-negative breast cancer: Multiple complete remissions. Metastatic pancreatic cancer: One patient disease-free after 5 years, now 6+ years and counting. FDA Roadblocks & Lost Time Despite undeniable success, Dr. Soon-Shiong faced years of resistance from regulators. In 2015, he proposed testing his method before chemo/radiation—but the FDA insisted on starting with end-stage patients. After 700,000 pages of submissions, approval finally came in late 2024. The Future: Beyond Cancer This treatment isn’t just for cancer—it’s showing promise against sepsis and severe infections. One recent case: A Valley Fever patient on a ventilator, given last rites—fully recovered after treatment. The Urgent Question Why is bureaucracy slowing down a therapy that could save millions? With pancreatic cancer, glioblastoma, and lung cancer patients still dying every day, how many more lives could have been saved if this had been fast-tracked?

Megyn Kelly sat down with Dr. Patrick Soon-Shiong to discuss his revolutionary cancer protocol—a treatment that has already extended lives by years for patients with terminal diagnoses, including the late Senator Harry Reid. The Science Behind the Breakthrough Dr. Soon-Shiong’s approach challenges conventional cancer treatments like chemotherapy and radiation, which destroy the immune system’s natural killer (NK) cells and T-cells—critical for fighting cancer. His BioStripe treatment works by rebuilding the immune system, even in patients who have exhausted all other options. Real Patients, Miraculous Results Merkel cell carcinoma (5th-line treatment): Complete remission—patient lived 6+ years and didn’t die from cancer. Bladder cancer: Patients still alive 10-11 years later. Triple-negative breast cancer: Multiple complete remissions. Metastatic pancreatic cancer: One patient disease-free after 5 years, now 6+ years and counting. FDA Roadblocks & Lost Time Despite undeniable success, Dr. Soon-Shiong faced years of resistance from regulators. In 2015, he proposed testing his method before chemo/radiation—but the FDA insisted on starting with end-stage patients. After 700,000 pages of submissions, approval finally came in late 2024. The Future: Beyond Cancer This treatment isn’t just for cancer—it’s showing promise against sepsis and severe infections. One recent case: A Valley Fever patient on a ventilator, given last rites—fully recovered after treatment. The Urgent Question Why is bureaucracy slowing down a therapy that could save millions? With pancreatic cancer, glioblastoma, and lung cancer patients still dying every day, how many more lives could have been saved if this had been fast-tracked?

Camus

615,537 görüntüleme • 1 yıl önce

Catch up on 𝘏𝘌𝘙2-mutant non-small cell lung cancer (NSCLC) data presented at ASCO 2026 Dr Herbert Loong, MBBS, FASCO & Dr Isabel Preeshagul joined us at ASCO 2026 to share their views on data emerging from the meeting 📺 Watch the video to get their expert insights on data from SOHO-01, Beamion LUNG-3, PRO results from the Beamion LUNG-1 trial, and advances in HER2 testing Programme endorsed by ICAN, International Cancer Advocacy Network, Biomarker Collaborative , Exon 20 Group, a multistakeholder organization & International Society of Liquid Biopsy Supported by an Independent Educational Grant from Bayer

Catch up on 𝘏𝘌𝘙2-mutant non-small cell lung cancer (NSCLC) data presented at ASCO 2026 Dr Herbert Loong, MBBS, FASCO & Dr Isabel Preeshagul joined us at ASCO 2026 to share their views on data emerging from the meeting 📺 Watch the video to get their expert insights on data from SOHO-01, Beamion LUNG-3, PRO results from the Beamion LUNG-1 trial, and advances in HER2 testing Programme endorsed by ICAN, International Cancer Advocacy Network, Biomarker Collaborative , Exon 20 Group, a multistakeholder organization & International Society of Liquid Biopsy Supported by an Independent Educational Grant from Bayer

LUNG CONNECT powered by COR2ED

841,885 görüntüleme • 29 gün önce

JUST IN: BRITISH DOCTOR IN GAZA LIVE UPDATE FROM A GAZA HOSPITAL He is LIVE from Gaza’s Frontlines. A British doctor shares an unfiltered, emotional look inside a war-torn hospital in Gaza. He is a friend from the UK, and what he describes over the various video updates is shocking. This is NOT news – this is real life. From treating trauma victims to operating with limited resources, this powerful video shows the brutal reality of healthcare under siege by the Israelis. From performing surgery on children to the fact that only one cancer doctor remains in all of Gaza, this video truly highlights how dire the situation is in Gaza. Share this post and let everyone know the brutal reality of what's happening in Gaza.

JUST IN: BRITISH DOCTOR IN GAZA LIVE UPDATE FROM A GAZA HOSPITAL He is LIVE from Gaza’s Frontlines. A British doctor shares an unfiltered, emotional look inside a war-torn hospital in Gaza. He is a friend from the UK, and what he describes over the various video updates is shocking. This is NOT news – this is real life. From treating trauma victims to operating with limited resources, this powerful video shows the brutal reality of healthcare under siege by the Israelis. From performing surgery on children to the fact that only one cancer doctor remains in all of Gaza, this video truly highlights how dire the situation is in Gaza. Share this post and let everyone know the brutal reality of what's happening in Gaza.

Sulaiman Ahmed

141,444 görüntüleme • 1 yıl önce

🚨URGENT situation in Charlotte, NC ... please share with everyone you know to bring attention to this horrifying story. A little boy named Judah could be medically kidnapped from his family after St. Jude Affiliate Clinic in Charlotte, NC accused them of medical “non-compliance” with absolutely no evidence in relation to his cancer treatments. The hospital referred them to CPS and has fired them as patients, putting the family in an absolutely desperate situation. In this case, Judah (because of complimentary holistic supplementation) has been in remission for leukemia for 21 months and is so healthy that the treatment center accused his parents of not administering oral chemotherapy - with absolutely no cause or evidence. Now, because he has no doctor to oversee his remaining treatments, the family will be 'out of compliance' and risk losing Judah to the state! This family is being terrorized and traumatized by the medical industrial complex ... WATCH ---->

🚨URGENT situation in Charlotte, NC ... please share with everyone you know to bring attention to this horrifying story. A little boy named Judah could be medically kidnapped from his family after St. Jude Affiliate Clinic in Charlotte, NC accused them of medical “non-compliance” with absolutely no evidence in relation to his cancer treatments. The hospital referred them to CPS and has fired them as patients, putting the family in an absolutely desperate situation. In this case, Judah (because of complimentary holistic supplementation) has been in remission for leukemia for 21 months and is so healthy that the treatment center accused his parents of not administering oral chemotherapy - with absolutely no cause or evidence. Now, because he has no doctor to oversee his remaining treatments, the family will be 'out of compliance' and risk losing Judah to the state! This family is being terrorized and traumatized by the medical industrial complex ... WATCH ---->

Shannon Joy

574,587 görüntüleme • 9 ay önce

⚠️ WARNING: This video contains images of self-harm and bullying which you may find disturbing ⚠️ Please share this with as many people as you can. Our desire is for all parents to watch . We aim to get this played in all schools to help those suffering from the effects of bullying, self harm , suicidal thoughts and most importantly, encourage them to open up and talk. Feel free to share your own personal stories below, we want this to be a space where we can encourage each other This is a short edit of ANOTHER WAY, the new music video by Fabio D'Andrea starring Peter Andre The full edit is available here:

⚠️ WARNING: This video contains images of self-harm and bullying which you may find disturbing ⚠️ Please share this with as many people as you can. Our desire is for all parents to watch . We aim to get this played in all schools to help those suffering from the effects of bullying, self harm , suicidal thoughts and most importantly, encourage them to open up and talk. Feel free to share your own personal stories below, we want this to be a space where we can encourage each other This is a short edit of ANOTHER WAY, the new music video by Fabio D'Andrea starring Peter Andre The full edit is available here:

Peter Andre

30,036 görüntüleme • 2 yıl önce